ECO Animal Health Group Plc

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2022-04 to 2023-03🗂️ Report periods on file: 2022-04 to 2023-03, 2021-04 to 2022-03

In its 2022-04 to 2023-03 reporting, ECO Animal Health Group Plc disclosed greenhouse gas emissions of 8.7 tCO2e (Southgate Office) + 6.3 tCO2e (New Malden Office) + other regional emissions (see Table 1 and 2). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
8.7 tCO2e (Southgate Office) + 6.3 tCO2e (New Malden Office) + other regional emissions (see Table 1 and 2)
2022-04 to 2023-03
⚡
Renewable Energy
81% green energy supplier (aiming for 100% in 2024)
of total energy
♻️
Waste
721 kgs of confidential paper recycled
2022-04 to 2023-03

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2022-04 to 2023-038.7 tCO2e (Southgate Office) + 6.3 tCO2e (New Malden Office) + other regional emissions (see Table 1 and 2)
2021-04 to 2022-0320 tCO2e/year (UK offices and fleet)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Increase employee satisfaction to above 80% in 2023-2024.
  • Improve lowest-performing areas in employee engagement by 5% in 2023-2024.
  • Switch to a 100% green energy supplier in 2024.
  • Every UK and European car renewal to be carbon-neutral or employee moved to a salary swap scheme.

📅 Medium-term

  • Achieve further 3% reduction in energy consumption per RMB turnover in 2023 by Chinese joint venture.
  • Add another NED with sector or market experience to the board.

🔭 Long-term

  • Aim to be carbon neutral by at least 2045.

🌱 ESG Focus Areas

EnvironmentDiversity, Equity, and Inclusion (DEI)Emissions

⚠️ Challenges & Risks +

  • High reliance on one supplier for key products.
  • Reliance placed on key directors, senior managers, and staff members.
  • High dependency on a single product (Aivlosin).
  • Potential threat from generic producers.
  • Disease impact on growth (African Swine Fever, Avian influenza).
  • Multiple new product launches in a single year and quality risk regarding new biologicals manufacturing.
  • Regulatory creep resulting in certain formulations not being sold in certain markets.
  • Political risk (e.g., Russia/Ukraine conflict) impacts markets through sanctions or trade difficulties.
  • Political risk – conflict or sanctions reduces supply of pig feed onto world markets which reduces customer margins and demand for the Group’s products.
  • Operational activities resulting in environmental pollution.

📋 Report Information

Reporting Period: 2022-04 to 2023-03
Frameworks: QCA Corporate Governance Code